Trial intelligence / Profile preview

Transdermal Lidocaine for IUD Insertion Pain

NCT04517890Unknown

Sponsor
Aswan University Hospital
Start
Sep 2020
Primary completion
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by Aswan University Hospital. Primary endpoint: The difference in pain scores during intrauterine device insertion at 10 minutes. Status: unknown.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT04517890.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04517890.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call